• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human SCRN3 Polyclonal Antibody

The antibody against SCRN3 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 100-410 of human SCRN3 (NP_078859.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

ADA-05652A

The antibody against SCRN3 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 100-410 of human SCRN3 (NP_078859.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-05652A ClonalityPolyclonal
Host SpeciesRabbitTarget NameSCRN3
Target SynonymsSES3; SCRN3FormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive Samples293T, A-549, HepG2ApplicationELISA, WB, IF/ICC

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 100-410 of human SCRN3 (NP_078859.2).Target SpeciesHuman
Uniprot IDQ0VDG4Immunogen Sequence
Background Information
  • Uniprot Id

    Q0VDG4

  • Target Species

    Human

  • Target Name

    SCRN3

  • Target Full Name

    Secernin-3

  • Target Synonyms

    SCRN3; Secernin-3

  • Target Background

    Predicted to enable cysteine-type exopeptidase activity and dipeptidase activity. Predicted to be involved in proteolysis.

Inquire Rabbit anti-Human SCRN3 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification